ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
Hungyuan B. Liu, Robert M. Brugger
Nuclear Technology | Volume 108 | Number 2 | November 1994 | Pages 151-156
Technical Paper | Fission Reactor | doi.org/10.13182/NT94-A35026
Articles are hosted by Taylor and Francis Online.
Convenient, economical epithermal neutron beams will be needed in the future for boron neutron capture therapy (BNCT). We studied two concepts for producing epithermal neutron beams with low-power reactors. The first design is a 100-kW reactor with a 235U fission plate placed outside the reflector region, plus an Al/Al2O3 moderator assembly. The beam, which is directed forward, delivers a flux of epithermal neutrons of 0.8 × 109 n/cm2·s and a fast neutron dose of 4.4 × 10−11 cGy·cm2/nepi. The second design is based on a slab reactor plus a similar Al/Al2O3 moderator assembly. With an operating power of 50 kW, the beam has an intensity of 1.4 × 109 n/cm2.s and a fast neutron dose of 4.6 × 10−11 cGy·cm2/nepi; this beam also is directed forward. These epithermal neutron beams should be acceptable for BNCT; a treatment could be completed in ∼1 h, and the fast neutron dose to the skin would not be the limiting dose. Such small reactors should be practicable in a hospital location.